529 related articles for article (PubMed ID: 25153274)
1. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.
Choi JY; Lee JM; Sirlin CB
Radiology; 2014 Sep; 272(3):635-54. PubMed ID: 25153274
[TBL] [Abstract][Full Text] [Related]
2. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.
Choi JY; Lee JM; Sirlin CB
Radiology; 2014 Oct; 273(1):30-50. PubMed ID: 25247563
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.
Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B
World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
[TBL] [Abstract][Full Text] [Related]
5. Hepatocarcinogenesis and LI-RADS.
Narsinh KH; Cui J; Papadatos D; Sirlin CB; Santillan CS
Abdom Radiol (NY); 2018 Jan; 43(1):158-168. PubMed ID: 29209739
[TBL] [Abstract][Full Text] [Related]
6. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.
Kim TH; Yoon JH; Lee JM
Korean J Radiol; 2019 Jun; 20(6):863-879. PubMed ID: 31132813
[TBL] [Abstract][Full Text] [Related]
7. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma.
Anysz-Grodzicka A; Podgorska J; Cieszanowski A
Curr Med Imaging Rev; 2019; 15(3):269-280. PubMed ID: 31989878
[TBL] [Abstract][Full Text] [Related]
8. Pathological variants of hepatocellular carcinoma on MRI: emphasis on histopathologic correlation.
Low HM; Choi JY; Tan CH
Abdom Radiol (NY); 2019 Feb; 44(2):493-508. PubMed ID: 30145629
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
[TBL] [Abstract][Full Text] [Related]
10. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
11. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
[TBL] [Abstract][Full Text] [Related]
12. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
14. [Imaging of pathological findings: hepatoma].
Honda H
Fukuoka Igaku Zasshi; 1998 Apr; 89(4):103-8. PubMed ID: 9597790
[No Abstract] [Full Text] [Related]
15. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
Santillan C; Fowler K; Kono Y; Chernyak V
Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
[TBL] [Abstract][Full Text] [Related]
16. Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT).
Silverman PM; Szklaruk J
Cancer Imaging; 2005 Dec; 5(1):178-87. PubMed ID: 16361147
[TBL] [Abstract][Full Text] [Related]
17. Extracapsular invasion of small hepatocellular carcinoma: MR and CT findings.
Imaeda T; Kanematsu M; Mochizuki R; Goto H; Saji S; Shimokawa K
J Comput Assist Tomogr; 1994; 18(5):755-60. PubMed ID: 8089325
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation.
Taouli B; Krinsky GA
Liver Transpl; 2006 Nov; 12(11 Suppl 2):S1-7. PubMed ID: 17051556
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.
Ayuso C; Rimola J; Vilana R; Burrel M; Darnell A; García-Criado Á; Bianchi L; Belmonte E; Caparroz C; Barrufet M; Bruix J; Brú C
Eur J Radiol; 2018 Apr; 101():72-81. PubMed ID: 29571804
[TBL] [Abstract][Full Text] [Related]
20. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
